Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Growing Pains is stocked at 199 licensed dispensaries across Michigan, with the deepest coverage in Detroit, New Buffalo, Monroe, Grand Rapids, and Flint. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Growing Pains concentrated 70.91% of sales in Flower, where year-over-year growth was 116.78% and month-over-month was 12.01%, while Pre-Roll expanded to 15.45% share with 617.23% YoY and 35.33% MoM growth. Concentrates held 11.12% share with 216.87% YoY and 25.42% MoM increases, contrasting with Vapor Pens at 2.52% share where YoY rose 149.46% but MoM fell 35.51%. Average price declined 26.45% YoY to $12.18 alongside a top state of Michigan, and a Flower rank position of 30 indicates mid-pack visibility; the pattern implies the brand is trading volume gains for price elasticity in inhalables while de-prioritizing Vapor Pens in the near term.
The tilt toward value-forward inhalables suggests a deliberate scale strategy: expanded share in Pre-Roll (+15.45% share) and Concentrates (+11.12% share) is compounding category breadth as Flower remains the anchor at the 30th rank, while Vapor Pens’ 35.51% MoM decline signals selective category pruning. With total brand sales up 153.92% YoY and a 237.97% two-year lift, the mix shift plus a 26.45% average price reduction indicates positioning around accessible price tiers that convert traffic into Flower and Pre-Roll baskets, implying the brand’s competitive posture will hinge on defending Flower rank while using Pre-Roll momentum to buffer seasonality and margin pressure.
Competitive Landscape
Growing Pains sits at rank #30 in MI Flower in October 2026, rising 53 positions year over year from #83, and improving 14 spots since July 2026 when it was #44. This month marks a peak rank of #30, while category leaders tightened at the top: High Minded held #1 with a 23.4% YoY sales increase, and Journey advanced from #7 to #2 alongside an 85.1% YoY lift, indicating that Growing Pains gained share faster in rank terms than mid-pack peers but trails the velocity at the top. The combination of a 53-rank YoY climb and a 14-rank improvement over three months implies a momentum-led re-entry into the competitive set, signaling runway to convert rank gains into sustained share if execution keeps pace with top-tier growth rates.
Notable Products
Growing Pains leans on hybrid Flower, with Hybrid accounting for 64.4% of sales in October 2026 and Pre-Rolls adding 14.3%, so the lineup is carried by inhalable formats. With the top 10 items contributing 43.5% and Lantz (Bulk) alone at 10.1%, most of its sales come from a relatively concentrated set of Flower SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.





